vs
Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and LINKBANCORP, Inc. (LNKB). Click either name above to swap in a different company.
IRONWOOD PHARMACEUTICALS INC is the larger business by last-quarter revenue ($47.7M vs $46.0M, roughly 1.0× LINKBANCORP, Inc.). LINKBANCORP, Inc. runs the higher net margin — 6.4% vs -4.8%, a 11.2% gap on every dollar of revenue. On growth, LINKBANCORP, Inc. posted the faster year-over-year revenue change (7.3% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $23.8M). Over the past eight quarters, LINKBANCORP, Inc.'s revenue compounded faster (6.6% CAGR vs -20.2%).
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
LINKBANCORP, Inc. is a US-based bank holding company that offers comprehensive retail and commercial banking services to individual consumers, small businesses, and mid-sized enterprises. Its core offerings include deposit accounts, lending products, wealth management solutions, and digital banking services, primarily serving customers across regional markets in Pennsylvania.
IRWD vs LNKB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.7M | $46.0M |
| Net Profit | $-2.3M | $2.9M |
| Gross Margin | — | — |
| Operating Margin | 14.3% | 8.5% |
| Net Margin | -4.8% | 6.4% |
| Revenue YoY | -47.3% | 7.3% |
| Net Profit YoY | -200.9% | -61.2% |
| EPS (diluted) | $0.01 | $0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.7M | $46.0M | ||
| Q3 25 | $122.1M | $44.8M | ||
| Q2 25 | $85.2M | $42.3M | ||
| Q1 25 | $41.1M | $53.4M | ||
| Q4 24 | $90.5M | $42.9M | ||
| Q3 24 | $91.6M | $42.9M | ||
| Q2 24 | $94.4M | $41.3M | ||
| Q1 24 | $74.9M | $40.5M |
| Q4 25 | $-2.3M | $2.9M | ||
| Q3 25 | $40.1M | $7.8M | ||
| Q2 25 | $23.6M | $7.4M | ||
| Q1 25 | $-37.4M | $15.3M | ||
| Q4 24 | $2.3M | $7.6M | ||
| Q3 24 | $3.6M | $7.1M | ||
| Q2 24 | $-860.0K | $5.8M | ||
| Q1 24 | $-4.2M | $5.7M |
| Q4 25 | 14.3% | 8.5% | ||
| Q3 25 | 61.8% | 22.3% | ||
| Q2 25 | 53.2% | 22.4% | ||
| Q1 25 | -70.7% | 36.0% | ||
| Q4 24 | 34.8% | 22.6% | ||
| Q3 24 | 28.0% | 21.3% | ||
| Q2 24 | 26.5% | 18.0% | ||
| Q1 24 | 14.7% | 18.1% |
| Q4 25 | -4.8% | 6.4% | ||
| Q3 25 | 32.8% | 17.5% | ||
| Q2 25 | 27.7% | 17.5% | ||
| Q1 25 | -90.9% | 28.7% | ||
| Q4 24 | 2.5% | 17.7% | ||
| Q3 24 | 4.0% | 16.5% | ||
| Q2 24 | -0.9% | 14.1% | ||
| Q1 24 | -5.6% | 14.1% |
| Q4 25 | $0.01 | $0.08 | ||
| Q3 25 | $0.23 | $0.21 | ||
| Q2 25 | $0.14 | $0.20 | ||
| Q1 25 | $-0.23 | $0.41 | ||
| Q4 24 | $0.03 | $0.21 | ||
| Q3 24 | $0.02 | $0.19 | ||
| Q2 24 | $-0.01 | $0.16 | ||
| Q1 24 | $-0.03 | $0.15 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $215.5M | $52.3M |
| Total DebtLower is stronger | — | $177.3M |
| Stockholders' EquityBook value | $-261.8M | $306.4M |
| Total Assets | $396.9M | $3.1B |
| Debt / EquityLower = less leverage | — | 0.58× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $215.5M | $52.3M | ||
| Q3 25 | $140.4M | $194.2M | ||
| Q2 25 | $92.9M | $155.1M | ||
| Q1 25 | $108.5M | $220.2M | ||
| Q4 24 | $88.6M | $166.1M | ||
| Q3 24 | $88.2M | $191.2M | ||
| Q2 24 | $105.5M | $181.7M | ||
| Q1 24 | $121.5M | $172.3M |
| Q4 25 | — | $177.3M | ||
| Q3 25 | $199.5M | $102.3M | ||
| Q2 25 | $199.3M | $102.3M | ||
| Q1 25 | $199.2M | $102.7M | ||
| Q4 24 | $199.0M | $112.5M | ||
| Q3 24 | $198.8M | $102.4M | ||
| Q2 24 | $198.6M | $102.3M | ||
| Q1 24 | $398.3M | $102.2M |
| Q4 25 | $-261.8M | $306.4M | ||
| Q3 25 | $-264.2M | $305.5M | ||
| Q2 25 | $-308.2M | $298.0M | ||
| Q1 25 | $-334.1M | $294.1M | ||
| Q4 24 | $-301.3M | $280.2M | ||
| Q3 24 | $-311.3M | $277.4M | ||
| Q2 24 | $-321.7M | $271.4M | ||
| Q1 24 | $-330.5M | $268.2M |
| Q4 25 | $396.9M | $3.1B | ||
| Q3 25 | $396.1M | $3.1B | ||
| Q2 25 | $342.9M | $2.9B | ||
| Q1 25 | $327.2M | $2.9B | ||
| Q4 24 | $350.9M | $2.9B | ||
| Q3 24 | $389.5M | $2.9B | ||
| Q2 24 | $395.6M | $2.9B | ||
| Q1 24 | $438.8M | $2.8B |
| Q4 25 | — | 0.58× | ||
| Q3 25 | — | 0.33× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.35× | ||
| Q4 24 | — | 0.40× | ||
| Q3 24 | — | 0.37× | ||
| Q2 24 | — | 0.38× | ||
| Q1 24 | — | 0.38× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $74.6M | $25.3M |
| Free Cash FlowOCF − Capex | $74.6M | $23.8M |
| FCF MarginFCF / Revenue | 156.3% | 51.7% |
| Capex IntensityCapex / Revenue | 0.0% | 3.2% |
| Cash ConversionOCF / Net Profit | — | 8.59× |
| TTM Free Cash FlowTrailing 4 quarters | $127.0M | $55.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $25.3M | ||
| Q3 25 | $47.6M | $23.6M | ||
| Q2 25 | $-15.1M | $6.3M | ||
| Q1 25 | $20.0M | $2.6M | ||
| Q4 24 | $15.2M | $25.4M | ||
| Q3 24 | $9.9M | $14.0M | ||
| Q2 24 | $33.5M | $6.4M | ||
| Q1 24 | $45.0M | $-771.0K |
| Q4 25 | $74.6M | $23.8M | ||
| Q3 25 | $47.6M | $23.2M | ||
| Q2 25 | $-15.1M | $6.1M | ||
| Q1 25 | $19.9M | $2.2M | ||
| Q4 24 | — | $22.6M | ||
| Q3 24 | $9.9M | $13.1M | ||
| Q2 24 | $33.4M | $6.3M | ||
| Q1 24 | $44.9M | $-1.2M |
| Q4 25 | 156.3% | 51.7% | ||
| Q3 25 | 39.0% | 51.8% | ||
| Q2 25 | -17.7% | 14.5% | ||
| Q1 25 | 48.4% | 4.2% | ||
| Q4 24 | — | 52.6% | ||
| Q3 24 | 10.8% | 30.5% | ||
| Q2 24 | 35.4% | 15.3% | ||
| Q1 24 | 60.0% | -3.0% |
| Q4 25 | 0.0% | 3.2% | ||
| Q3 25 | 0.0% | 0.8% | ||
| Q2 25 | 0.0% | 0.4% | ||
| Q1 25 | 0.1% | 0.7% | ||
| Q4 24 | 0.0% | 6.7% | ||
| Q3 24 | 0.0% | 2.1% | ||
| Q2 24 | 0.1% | 0.1% | ||
| Q1 24 | 0.1% | 1.1% |
| Q4 25 | — | 8.59× | ||
| Q3 25 | 1.19× | 3.01× | ||
| Q2 25 | -0.64× | 0.85× | ||
| Q1 25 | — | 0.17× | ||
| Q4 24 | 6.74× | 3.35× | ||
| Q3 24 | 2.71× | 1.97× | ||
| Q2 24 | — | 1.10× | ||
| Q1 24 | — | -0.13× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
